Photoredox-Mediated C–H Functionalization and Coupling of Tertiary Aliphatic Amines with 2-Chloroazoles
摘要:
Herein, conditions for C-H functionalization of tertiary aliphatic amines and their subsequent coupling with a number of 2-chloroazole derivatives are reported. The reaction is facilitated by a catalytic amount of tris-fac-Ir(ppy)3, with blue light irradiation and takes place under mild and convenient conditions. Most couplings take place with excellent regioselectivity. The reaction is tolerant of a number of functional groups and allows for rapid access to alpha-azole carbinamines commonly found in post-translationally modified peptides.
Photoredox-Mediated C–H Functionalization and Coupling of Tertiary Aliphatic Amines with 2-Chloroazoles
摘要:
Herein, conditions for C-H functionalization of tertiary aliphatic amines and their subsequent coupling with a number of 2-chloroazole derivatives are reported. The reaction is facilitated by a catalytic amount of tris-fac-Ir(ppy)3, with blue light irradiation and takes place under mild and convenient conditions. Most couplings take place with excellent regioselectivity. The reaction is tolerant of a number of functional groups and allows for rapid access to alpha-azole carbinamines commonly found in post-translationally modified peptides.
[EN] COMPOUNDS AND THERAPEUTIC USES THEREOF<br/>[FR] COMPOSÉS ET SES UTILISATIONS THÉRAPEUTIQUES
申请人:MYREXIS INC
公开号:WO2012177782A1
公开(公告)日:2012-12-27
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and complications associated with these diseases and disorders.
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.
本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。
[EN] LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID DELIVERY<br/>[FR] COMPOSITIONS DE PEPTIDE-PEG CATIONIQUE LIPIDÉ DESTINÉES À L'ADMINISTRATION D'ACIDES NUCLÉIQUES
申请人:NUTCRACKER THERAPEUTICS INC
公开号:WO2021030218A1
公开(公告)日:2021-02-18
The present disclosure relates to complexes and compositions of cationic compounds combined with low mass percentages of PEGylated compounds, such as PEGylated lipids, for the delivery of nucleic acids and other polyanionic cargoes to cells, methods for preparing complexes and compositions comprising one or more cationic compounds and a low mass percentage of PEGylated compounds with polyanionic compounds, and methods for delivering the polyanionic compounds to cells.